Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Computational design of binding proteins to EGFR domain II.

Choi YS, Yoon S, Kim KL, Yoo J, Song P, Kim M, Shin YE, Yang WJ, Noh JE, Cho HS, Kim S, Chung J, Ryu SH.

PLoS One. 2014 Apr 7;9(4):e92513. doi: 10.1371/journal.pone.0092513. eCollection 2014.

2.

Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.

Zhou Y, Zhang J, Jin H, Chen Z, Wu Q, Li W, Yue M, Luo C, Wang M.

Biomed Pharmacother. 2013 Oct;67(8):737-43. doi: 10.1016/j.biopha.2013.03.019. Epub 2013 Apr 18.

PMID:
23639232
3.

Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses.

Moonrin N, Songtawee N, Rattanabunyong S, Chunsrivirot S, Mokmak W, Tongsima S, Choowongkomon K.

BMC Bioinformatics. 2015 Mar 27;16:103. doi: 10.1186/s12859-015-0528-x.

4.

Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display.

Chao G, Cochran JR, Wittrup KD.

J Mol Biol. 2004 Sep 10;342(2):539-50. Erratum in: J Mol Biol. 2005 Mar 11;346(5):1455.

PMID:
15327953
5.

Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.

Steiner D, Forrer P, Plückthun A.

J Mol Biol. 2008 Oct 24;382(5):1211-27. doi: 10.1016/j.jmb.2008.07.085. Epub 2008 Aug 6.

6.

Identification of new peptide ligands for epidermal growth factor receptor using phage display and computationally modeling their mode of binding.

Hamzeh-Mivehroud M, Mahmoudpour A, Dastmalchi S.

Chem Biol Drug Des. 2012 Mar;79(3):246-59. doi: 10.1111/j.1747-0285.2011.01282.x. Epub 2012 Jan 11.

PMID:
22136656
7.

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

Friedman M, Nordberg E, Höidén-Guthenberg I, Brismar H, Adams GP, Nilsson FY, Carlsson J, Ståhl S.

Protein Eng Des Sel. 2007 Apr;20(4):189-99. Epub 2007 Apr 23.

PMID:
17452435
8.

Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.

Kozer N, Kelly MP, Orchard S, Burgess AW, Scott AM, Clayton AH.

Biochemistry. 2011 May 10;50(18):3581-90. doi: 10.1021/bi101785h. Epub 2011 Apr 15.

PMID:
21495621
9.

Screening of specific internalization Fab fragment from human naive phage library by combinational bio-panning.

Wang X, Cao BB.

Methods Mol Biol. 2009;525:161-74, xv. doi: 10.1007/978-1-59745-554-1_8.

PMID:
19252831
10.

A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.

Tsou YA, Chen KC, Chang SS, Wen YR, Chen CY.

J Biomol Struct Dyn. 2013 Dec;31(12):1358-69. doi: 10.1080/07391102.2012.736773. Epub 2012 Nov 12.

PMID:
23140436
11.

Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.

Talavera A, Friemann R, Gómez-Puerta S, Martinez-Fleites C, Garrido G, Rabasa A, López-Requena A, Pupo A, Johansen RF, Sánchez O, Krengel U, Moreno E.

Cancer Res. 2009 Jul 15;69(14):5851-9. doi: 10.1158/0008-5472.CAN-08-4518. Epub 2009 Jul 7. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

12.

B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).

Zhu L, Zhao L, Wu M, Chen Z, Li H.

Immunol Lett. 2013 Jun;153(1-2):33-40. doi: 10.1016/j.imlet.2013.07.003. Epub 2013 Jul 18.

PMID:
23871733
13.

Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.

Johns TG, Adams TE, Cochran JR, Hall NE, Hoyne PA, Olsen MJ, Kim YS, Rothacker J, Nice EC, Walker F, Ritter G, Jungbluth AA, Old LJ, Ward CW, Burgess AW, Wittrup KD, Scott AM.

J Biol Chem. 2004 Jul 16;279(29):30375-84. Epub 2004 Apr 9.

14.

Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.

La Motta C, Sartini S, Tuccinardi T, Nerini E, Da Settimo F, Martinelli A.

J Med Chem. 2009 Feb 26;52(4):964-75. doi: 10.1021/jm800829v.

PMID:
19170633
15.

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S.

Cell. 2002 Sep 20;110(6):775-87.

16.

Activation of the epidermal growth factor receptor: a series of twists and turns.

Poger D, Mark AE.

Biochemistry. 2014 Apr 29;53(16):2710-21. doi: 10.1021/bi401632z. Epub 2014 Apr 17.

PMID:
24697572
17.

Ligand binding induces a conformational change in epidermal growth factor receptor dimers.

Walker F, Rothacker J, Henderson C, Nice EC, Catimel B, Zhang HH, Scott AM, Bailey MF, Orchard SG, Adams TE, Liu Z, Garrett TP, Clayton AH, Burgess AW.

Growth Factors. 2012 Dec;30(6):394-409. doi: 10.3109/08977194.2012.739619. Epub 2012 Nov 20.

PMID:
23163584
18.

Recombinant human IgG antibodies recognizing distinct extracellular domains of EGF receptor exhibit different degrees of growth inhibitory effects on human A431 cancer cells.

Chang C, Takayanagi A, Yoshida T, Shimizu N.

Exp Cell Res. 2013 May 1;319(8):1146-55. doi: 10.1016/j.yexcr.2013.03.002. Epub 2013 Mar 13.

PMID:
23499740
19.

A basic peptide within the juxtamembrane region is required for EGF receptor dimerization.

Aifa S, Aydin J, Nordvall G, Lundström I, Svensson SP, Hermanson O.

Exp Cell Res. 2005 Jan 1;302(1):108-14.

PMID:
15541730
20.

Supplemental Content

Support Center